Physician

David Paul Fivenson, MD

According to 2025 Medicare claims, David Fivenson, MD (NPI: 1235193525) practices dermatology in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is DAVID FIVENSON, M.D.DERMATOLOGY, PLLC (NPI: 1205037454; TIN: 810563722) and primary practice location at 48103-2122. Fivenson is affiliated with the McAuley Health Partners ACO, LLC (ACO ID: A4588), participating under the MSSP model.

Fivenson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 416 traditional Medicare patients, billed 1,674 HCPCS/CPT codes, and received $98,210 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,966 prescription claims across 383 beneficiaries totaling $1,526,569 in drug costs, led by Dupixent Pen (Dupilumab). 2020 DME data shows 195 claims. Open Payments data shows 154 records totaling $221,094. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments moved sharply higher in recent years, from $17,828 to $58,464.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	462	2,122	$120,308
2016	402	2,249	$120,423
2017	428	2,156	$117,459
2018	481	2,736	$178,904
2019	484	2,420	$151,023
2020	382	1,722	$95,559
2021	427	1,660	$115,074
2022	438	1,976	$126,848
2023	418	1,847	$113,745
2024	416	1,674	$98,210

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	1,542	$1,486,664
2016	289	1,668	$987,146
2017	287	1,661	$1,257,241
2018	319	1,946	$1,283,289
2019	331	1,784	$1,294,052
2020	316	1,843	$1,391,950
2021	341	1,815	$1,499,387
2022	344	1,836	$1,564,460
2023	381	2,051	$1,651,153
2024	383	1,966	$1,526,569

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	60	$14,935
2016	N/R	27	$1,657
2017	N/R	N/R	N/R
2018	N/R	183	$92,498
2019	N/R	163	$64,398
2020	N/R	195	$83,954
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	81	164	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	168	219	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	127	155	$61
17000	Destruction of precancer skin growth, 1 growth	108	127	$39
17003	Destruction of precancer skin growth, 2-14 growths	78	427	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	64	1,764	$238,479
Taltz Autoinjector	Ixekizumab	18	840	$193,763
Otezla	Apremilast	24	720	$94,174
Sotyktu	Deucravacitinib	12	360	$81,388
Xeljanz Xr	Tofacitinib Citrate	14	420	$80,631

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$11,145	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	138	$209,949	Incyte Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Paul Fivenson, MD?

Tedicare shows public-source Medicare data for David Paul Fivenson, MD (NPI 1235193525), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Paul Fivenson, MD have ACO affiliation data?

David Paul Fivenson, MD is shown with ACO affiliation data for McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588).

What billing organization is linked to David Paul Fivenson, MD?

David Paul Fivenson, MD is linked to DAVID FIVENSON, M.D.DERMATOLOGY, PLLC (billing NPI 1205037454) in the available physician profile data.

Does David Paul Fivenson, MD have Open Payments data?

David Paul Fivenson, MD has 154 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.